diabetes are not surprising given that subjects differed with respect to extent of obesity, age, gender and ethnic group. In the literature, most of the studies on serum leptin in type 2 diabetes have focused on white populaf f tions. In this study we investigated leptin concentrations and parameters related to glycemic control in Arabs with type 2 diabetes and in matched normal control subjects. We also assessed the relationship between leptin and anf f thropometric and metabolic variables.
SUBJECTS AND METHODS
Ninetyftwo Arab patients with type 2 diabetes melf f litus and 69 normal control subjects were included in the study. The patients and controls were matched by ethnic group, age, gender and body mass index (BMI). Patients had been diabetic for a median of 6 years (range, 0.5f20.5 years). They were recruited from the endocrine clinics of Mubarak AlfKabeer Hospital and the Hawalli region in Kuwait. Twelve patients were treated with diet only, 54 patients were treated with oral antifdiabetic agents and 26 were on insulin therapy. No patient or control had other known illness and none of the patients or controls was taking medications other than their antifdiabetic therapy (except for 42 patients taking either ACE inhibitors or angiotensin receptor blockers, 36 taking either statins or fibrates and 39 takf f ing lowfdose aspirin). Controls were healthy subjects who in the last 12 months were not taking any medicaf f tion and had no family history of diabetes mellitus. The study protocol was approved by the local ethics comf f mittee and patients gave written informed consent.
Anthropometric measurements (including waist and hip) and blood pressures were assessed in all subjects. The waist and hip circumferences were measured usf f ing a flexible measuring tape directly applied to the subf f ject' s skin. The narrowest waist and widest hip circumf f ferences were taken (after taking the average of three measurements for each individual). After 12 hours of an overnight fast, blood was collected for the measuref f ment of serum leptin, glucose, insulin, Cfpeptide, intact proinsulin, insulinflike growth factor 1 (IGFf1), lipids and hemoglobin A1c (HbA 1c Blood samples were immediately centrifuged at 2500 rpm at 4ºC for 15 minutes and the supernatants were stored at f70ºC until analysis. Serum leptin was meaf f sured by radioimmunoassay (Human Leptin RIA kit, Linco Research, St. Charles, Missouri, USA). 22 Plasma glucose, triglycerides and total cholesterol were meaf f sured by an enzymatic colorimetric test using an autof f matic colorimeter (Hitachi 717, Boehringer Mannheim Gmbh Diagnostica, Mannheim, Germany). Insulin and Cfpeptide concentrations were measured by radioimf f munoassay and the double antibody Cfpeptide kit was used for the measurement of Cfpeptide. 23 Intact prof f insulin was measured by an ELISA method (DAKO Diagnostica, Cambridgeshire, UK). IGFf1 was meaf f sured by an ELISA (Diagnostic System Laboratories, Texas, USA). The interfassay and intrafassay coeffif f cients of variation (CV) were 3.4% and 2.5% for leptin (at 5.8 µg/L), 1.4% and 1.2% for triglycerides (at 1.2 mmol/L), 3.3% and 2.8% for total cholesterol (at 3.5 mmol/ L), 7.0% and 7.8% for insulin (at 30.7 mU/L), 1.9% and 3.0% for Cfpeptide (at 2929 pmol/L), 4.5% and 5.2% for intact proinsulin (at 4.2 pmol/L), and 3.1% and 6.0% for IGFf1 (at 16µg/ L), respectively. Hemoglobin, packed cell volume, white cell count, platelets, and liver and renal function were measured by routine laboratory techniques.
Data are expressed as mean and the standard error of the mean or median and range. Data in patients and controls were compared using the MannfWhitney U test or the unpaired t test as appropriate. Correlation between variables was sought using the Spearman rank correlaf f tion coefficient (rho). Nonfnormally distributed variables (insulin, Cfpeptide and intact proinsulin) were normalf f ized by logftransformation prior to analysis. The Statview program was used for statistical analysis. Differences were considered statistically significant when the P value was <.05.
RESULTS
Hemoglobin, white cell count, packed cell volume, platef f lets, creatinine, and liver function tests were within the norf f mal range and similar in patients and controls. Glycemic control in the patients was excellent in 9 patients (10%), very good in 12 (13%), good in 40 (44%), acceptable in 12 (13%), and poor in 19 patients (20%). Patients tended to have a higher waist circumference, waistftofhip ratio and diastolic blood pressure than controls (Table 1) .
Fasting serum leptin levels were similar in patients with type 2 diabetes and control subjects. When obese subjects (BMI ≥30 kg/m 2 ) were analyzed separately, serum levels of leptin were significantly lower in obese patients compared to obese controls (Table 2) , and the differences in leptin remained significant even after corf f rections for the differences in insulin. Women in each group had significantly higher leptin levels than men (patients, P=.03; controls, P=.002). Gender differences 
DISCUSSION
It has recently been shown that leptin levels display ethf f nic differences. For example, a large population study from the United States has showed that leptin levels were higher in nonfHispanic blacks than in whites with subjects of MexicanfAmerican origin having leptin levels in between. 24 Inhabitants of the Pacific island of Kitava had lower leptin levels than whites, 25 whereas subjects of south Asian origin seem to have a higher leptin level than whites or Chinese. 26, 27 In subjects of African origin, the information is not conclusive since studies showing higher leptin than in other ethnic groups 24 or no differf f ence 28, 29 have been published. To further explore whethf f er differences exist in leptin levels in Arabs with and without diabetes, we assessed leptin levels in obese and nonfobese Arabs with type 2 diabetes and in obese and nonfobese normal control Arabs. We demonstrated that leptin levels are similar in nonfobese type 2 diabetics compared with matched nonfobese controls. However, leptin was lower in obese type 2 diabetics than in obese controls even after correction for the differences in insuf f lin levels between the two groups.
Most crossfsectional studies have shown no differf f ence in leptin levels between diabetic and nonfdiabetic individuals of similar body weight. 30f36 One study in Saudi Arabian male patients with metabolic syndrome (and type 2 diabetes) and coronary artery disease demf f onstrated increased levels of leptin in patients compared with controls. 37 However, there is a single report of reduced leptin levels in obese individuals with poorly controlled diabetes. 38 Consistent with our findings is a recent report that obese type 2 diabetics had lower leptin levels than obese control subjects. 38 In the same study, obese subjects with less betafcell dysfunction and conf f trolled diabetes had leptin levels only slightly lower than those of control subjects. These results were similar to our findings of a negative association between leptin and HbA 1c . Moreover, if all subjects (obese and nonfobese) had been combined into a single group, 38 the difference in leptin levels compared with control subjects would have been attenuated as was the case in our study, and this was reflected clearly when a multivariable regression analysis was applied and HbA 1c did not seem to be an independently associated variable in our study.
Similarly, the association between high leptin levels and subsequent weight gain deserves attention. Pima Indians who gained at least 3.0 kg/year had lower basef f line leptin levels than those whose weight remained staf f ble.
39 It remains to be seen how these findings compare with studies in other populations. Nevertheless, our study design does not allow definitive testing of these hyf f potheses since we do not know the time of diabetes onf f set in relation to changes in insulin secretion or changes in body fat or weight. Our finding of the significant posif f tive correlations between serum leptin and measures of adiposity like BMI was in agreement with observations 38f40 However, the observed negaf f tive relationship between leptin and waistftofhip ratio in this group of subjects seems difficult to explain, but less association was found by multiple regression analysis. An opposite relationship between leptin and waistftof hip ratio was found for different age groups of women; there was a positive relationship in prefmenopausal and a negative relationship in postmenopausal women. 41 In our study, however, similar numbers of postmenopausal subjects (patients and controls) were studied (less than 10 subjects) and none of the subjects was taking horf f monefreplacement therapy.
In conclusion, nonfobese Arabs with type 2 diaf f betes have leptin levels similar to control subjects. However, obesity in Arabs with type 2 diabetes is associated with low serum leptin levels. This probf f ably suggests that leptin levels display an ethnic difference.
